Hyaluronan Deficiency in Tumor Stroma Impairs Macrophage Trafficking and Tumor Neovascularization

Despite the importance of stromal cells in tumor progression, our overall understanding of the molecular signals that regulate the complex cellular interactions within tumor stroma is limited. Here, we provide multiple lines of evidence that tumor-associated macrophages (TAM) preferentially traffic...

Full description

Saved in:
Bibliographic Details
Published inCancer research (Chicago, Ill.) Vol. 70; no. 18; pp. 7073 - 7083
Main Authors KOBAYASHI, Nobutaka, MIYOSHI, Seiji, OGURI, Kayoko, OKAYAMA, Minoru, MCDONALD, John A, KIMATA, Koji, TANIGUCHI, Shun'ichiro, ITANO, Naoki, MIKAMI, Takahide, KOYAMA, Hiroshi, KITAZAWA, Masato, TAKEOKA, Michiko, SANO, Kenji, AMANO, Jun, ISOGAI, Zenzo, NIIDA, Shumpei
Format Journal Article
LanguageEnglish
Published Philadelphia, PA American Association for Cancer Research 15.09.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Despite the importance of stromal cells in tumor progression, our overall understanding of the molecular signals that regulate the complex cellular interactions within tumor stroma is limited. Here, we provide multiple lines of evidence that tumor-associated macrophages (TAM) preferentially traffic to stromal areas formed within tumors in a manner dependent on a hyaluronan (HA)-rich tumor microenvironment. To address the role of stroma-derived HA in macrophage recruitment, we disrupted the HA synthase 2 (Has2) gene in stromal fibroblasts using conditional gene targeting. The Has2 null fibroblasts showed severe impairment in recruiting macrophages when inoculated with tumor cells into nude mice, which shows the contribution of stroma-derived HA in intratumoral macrophage mobilization. Furthermore, a deficiency in stromal HA attenuated tumor angiogenesis and lymphangiogenesis concomitantly with impaired macrophage recruitment. Taken together, our results suggest that stromal HA serves as a microenvironmental signal for the recruitment of TAMs, which are key regulatory cells involved in tumor neovascularization.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0008-5472
1538-7445
DOI:10.1158/0008-5472.can-09-4687